Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Dexmedetomidine + Melatonin for Post-operative Delirium in Open Brain Surgeries
NCT07475156Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Aug 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of melatonin in postoperative delirium (POD) (2 arms), sponsored by Ain Shams University. Primary endpoint: Incidence of Post-operative Delirium. Started Aug 2025; status: completed.
02
Drugs
melatonin
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT07475156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07475156.